Kenta Yagi Selected Research

1-hydroxycyclohexyl phenyl ketone

1/2015

Photoinitiator-Initiated Estrogenic Activity in Human Breast Cancer Cell Line MCF-7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenta Yagi Research Topics

Disease

3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2020
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 09/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2021
2	Nausea 01/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 09/2020
2	Vomiting 01/2021 - 01/2021
1	Muscular Diseases (Myopathy) 10/2022
1	Rhabdomyolysis 10/2022
1	Cardiotoxicity 08/2022
1	Fibrosis (Cirrhosis) 08/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2022
1	Hyperalgesia 04/2022
1	Dyslipidemias (Dyslipidemia) 04/2022
1	Malignant Mesothelioma 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Exanthema (Rash) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	COVID-19 11/2020
1	Aortic Dissection 09/2020
1	Aneurysm (Aneurysms) 09/2020
1	Atherosclerosis 09/2020
1	Acute Aortic Syndrome 09/2020
1	Aortic Diseases 09/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 09/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2018
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Carcinogenesis 01/2014
1	Necrosis 01/2013

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 08/2022 - 11/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 04/2022
2	Simvastatin (Zocor)FDA LinkGeneric 10/2022 - 04/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	O(4)-methylthymidine monophosphateIBA 01/2015 - 01/2013
1	Atorvastatin (Lipitor)FDA Link 10/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022
1	Sirolimus (Rapamycin)FDA Link 08/2022
1	AnthracyclinesIBA 08/2022
1	CytokinesIBA 08/2022
1	mosaprideIBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	Messenger RNA (mRNA)IBA 08/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	palbociclibIBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	abemaciclibIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2021
1	XELOXIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Androgen Antagonists (Antiandrogens)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	QuercetinIBA 09/2020
1	Angiotensin IIIBA 09/2020
1	AminopropionitrileIBA 09/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 09/2020
1	FlavonoidsIBA 09/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 04/2018
1	Estrogens (Estrogen)FDA Link 01/2015
1	padimate-OIBA 01/2015
1	1-hydroxycyclohexyl phenyl ketoneIBA 01/2015
1	2,2-dimethoxy-2-phenylacetophenoneIBA 01/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	ProstaglandinsIBA 01/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Oral Administration 08/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Radiotherapy 01/2021